Want to see AU:TRI full AI Analyst Report?
TRI Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume234.85K
Average Volume (3M)441.28K
Market Cap
AU$17.31M
Enterprise ValueAU$21.91
Total Cash (Recent Filing)AU$2.44M
Total Debt (Recent Filing)AU$128.14K
Price to Earnings (P/E)―
Beta2.09
Next Earnings
Feb 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding1,153,693,500
10 Day Avg. Volume447,200
30 Day Avg. Volume441,280
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.01
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageMinimal debt limits creditor claims on cash flow and reduces refinancing pressure. This gives the company greater financial flexibility than a highly leveraged business, although ongoing losses could still weaken that position.
Growing Asset BaseThe increase in total assets indicates balance-sheet expansion and a larger resource base supporting operations. However, its long-term value depends on whether the company can convert those resources into revenue and sustainable cash generation.
Substantial Equity Relative To DebtA substantial equity base relative to debt provides structural protection from excessive interest and principal obligations. It may support strategic investment or restructuring, but persistent losses could erode equity and reduce this advantage.
Bears Say
No Reported RevenueThree consecutive years of zero reported revenue show that a functioning revenue engine is not visible in the financial statements. This severely limits operating self-sufficiency and creates uncertainty about the company's commercial scalability.
Worsening LossesThe sharp deterioration in profitability indicates that the cost base remains unsupported by reported sales. If this trend persists, it can erode equity, constrain investment capacity, and increase the likelihood of additional capital requirements.
Persistent Operating Cash BurnPersistent negative operating cash flow means the business is not funding its activities internally. The worsening 2026 burn increases dependence on existing balance-sheet resources or external funding until profitability and cash conversion improve.
TrivarX Limited News
TRI FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is TrivarX Limited’s market cap?
TrivarX Limited’s market cap is AU$17.31M.
When is TrivarX Limited’s upcoming earnings report date?
TrivarX Limited’s upcoming earnings report date is Feb 19, 2027 which is in 163 days.
How were TrivarX Limited’s earnings last quarter?
TrivarX Limited released its earnings results on Aug 27, 2026. The company reported -AU$0.954 earnings per share for the quarter.
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 1,153,693,500 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
TrivarX Limited reported an EPS of -AU$0.954 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in AU:TRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TrivarX Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
8.33%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
29.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
TrivarX Limited
Operating as a health technology enterprise, TrivarX Limited specializes in crafting artificial intelligence-driven, scientifically validated instruments designed for the assessment and identification of behavioral health disorders. Its market presence extends across Australia and the United States. The company delivers mental well-being provisions tailored for corporate clients through its enterprise health offerings, concurrently developing solutions for medical service providers. Established in 1987, the entity was formerly known as Medibio Limited until its rebranding as TrivarX Limited in October 2023. Its principal place of business is situated in Mount Lawley, Australia.
Technical Analysis
Resonance Health Ltd
―
Opyl Ltd.
―
MedAdvisor Limited
―
InteliCare Holdings Limited
―
PainChek Ltd
―